L. Salabert

Deciphering the complex role of thrombospondin-1 in glioblastoma development

F. Falciani, É. Darbo, R. Bjerkvig, 2019, Nature Communications.

Abstract PD8-02: Trastuzumab deruxtecan (T-DXd) for advanced breast cancer patients (ABC), regardless HER2 status: A phase II study with biomarkers analysis (DAISY)

F. André, M. Lacroix-Triki, T. Petit, 2022, Cancer Research.

Deciphering the complex role of thrombospondin-1 in glioblastoma development

F. Falciani, É. Darbo, R. Bjerkvig, 2019, Nature Communications.

260P Antitumor activity of trastuzumab deruxtecan (T-DXd) in patients with metastatic breast cancer (mBC) and brain metastases (BMs) from DAISY trial

J. Pierga, X. Durando, V. Diéras, 2022, Annals of Oncology.

Adenosquamous Carcinoma of the Pancreas

D. Béchade, L. Salabert, H. Del Arco, 2019, Clinical Medicine Insights. Oncology.

Renal cell carcinoma lung metastases treated by radiofrequency ablation integrated with systemic treatments: over 10 years of experience

A. Ravaud, X. Buy, V. Brouste, 2019, BMC Cancer.

Abstract P1-18-28: Phase IV study evaluating effectiveness and safety of talazoparib in patients with locally advanced or metastatic HER2 negative breast cancer and a BRCA1 or BRCA2 mutation (ViTAL)

P. Pujol, N. Dohollou, Jean-David Fumet, 2022, Cancer Research.